Preventative Healthcare for Rural Communities

By /

This virtual dialogue will bring together public health professionals, healthcare practitioners, and administrators who are recognized as subject matter experts and key opinion leaders from both the U.S. and China to explore innovative strategies to advance preventative healthcare in rural communities in both countries.

This initial virtual session will address the unique challenges and opportunities in evaluating and implementing evidence-based preventative practices in underserved rural areas. Using Kotter’s 8-Step Change Model as a leadership framework, participants will engage in discussions to identify actionable pathways to improve cancer screening, obesity prevention, and nutrition interventions.

Register to Attend

Click Here

Participants

Panelist

Kim D. French

MHSA, CAPPM, FCCP - Vice President Lung Programs for Ascension Health System in Chicago

Kim D. French

Suburban Lung is a regionally-recognized specialty practice in pulmonary, critical care, sleep, allergy & immunology, and interventional pulmonary medicine. In 1995, French relocated to Chicago joining Suburban Lung and grew the practice to 36 providers. French has been integral to business, clinical, and quality care initiatives. Demonstrated accomplishments in the areas of physician alignment, design and operation of efficient, quality-based care models, electronic health record implementation, including achieving Meaningful Use, PQRS, and E RX incentives, as well as service line growth and hospital-practice contracting including 24/7 intensivist services at multiple hospitals, advanced lung diagnostic testing, interventional pulmonology services in collaboration with University of IL Health System, and a PSA for in-practice DME.

French holds a Master’s Degree in Health Services Administration from Russell Sage College, Troy, NY and is a Certified Administrator in Physician Practice Management through the American Academy of Medical Management. She is a Board of Trustee of the CHEST Foundation (ACCP) and past member of the ACCP Practice Management Committee, Marketing Committee, and past Chair of the Practice Operations Network. French has worked as staff liaison for the ACCP to the Practice Expense Advisory Committee (PEAC) and the RVS Update Committee (RUC) of the AMA.

French is the co-author of several practice management publications in CHEST, CHEST Physician, and Coding for CHEST Medicine. She is a past Advisory Board member for Gallagher Healthcare and currently Harper College. She is a long-standing member of the MGMA and over the years has held committee appointments at both Central DuPage Hospital and Alexian Brothers Medical Center. As an active member in her community, she is a past Parent Board member, St. Francis High School, Wheaton, IL, previous Co-Chair of the Hospitality Committee and volunteers at charity organizations throughout the year.

Kim French's Bio

Panelist

Gordon Liu, Ph.D.

Dean of the Peking University Institute for Global Health and Development

Gordon Liu, Ph.D.

Gordon G. LIU, PhD., Dean of PKU Institute for Global Health and Development, PKU BOYA Distinguished Professor of Economics, MOE Yangtze River Scholar Professor of Economics at PKU National School of Development, and Director of PKU China Center for Health Economic Research. Previously, he was on fulltime faculty at University of Southern California, UNC-Chapel Hill, PKU Guanghua School of Management. He served as the President of Chinese Economists Society, and founding chair of the ISPOR Asian Pacific Consortium. Currently, Prof. Liu is a co-organizer for the US-China Track II Dialogue on Health, and he is a member of China National Expert Panel on Covid-19, as well as on the State Council Health Reform Advisory Commission. He chairs the China Pharmacoeconomic Society, and co-chairs the Health Thematic Group of the UN Sustainable Development and Solution Network (SDSN) Leadership Council led by Jeffrey Sachs of Columbia University. Prof. Liu has served as Associate Editor for academic journals including Health Economics (HE), Value in Health (The ISPOR official journal), and China Economic Quarterly (CEQ). He received PhD in Economics from CUNY Graduate Center, and post-doctoral training in health economics from Harvard University, focusing on research areas in health and development economics, health policy reform, and health technology assessment.

Gordon Liu's Bio

Panelist

Susan Garwood, MD

National Physician Director for Pulmonary Disease at HCA Healthcare

Susan Garwood

Susan Garwood, MD received her medical degree from University of Texas at Houston Medical School in Houston Texas. She completed an Internal Medical residency at Vanderbilt University in Nashville, TN. She also completed her Pulmonary and Critical Care fellowship at Medical University of South Carolina. She is a member of the ACCP, ATS and The American Medical Association. Dr. Garwood is also board certified in Pulmonary and Critical Care medicine. Her time outside of patient care is dedicated to her two children. She enjoys travel, reading, exercise and spending time with family.

Susan Garwood's Bio

Panelist

Dr. Lizheng Shi

Director, Health Systems Analytics Research Center at Tulane University in New Orleans

Lizheng Shi

Lizheng Shi trained as a pharmacist (BS in pharmacy 1992, MS in pharmacy 1994) through Shanghai Medical University and Peking Union Medical College, respectively. He has also trained as an economist (MA in economics 1998, PhD in pharmaceutical economics and policy 2001) through the University of Southern California. He is the Endowed Regents Professor in the department of Health Policy and Management, and he serves as clinical faculty in departments of medicine (endocrinology) and psychiatry. He is the director for Health Systems Analytics Research Center (HSARC). He is a member of the editorial board for pharmacoeconomics. Dr. Shi’s current research interest includes health technology assessment and healthcare quality, access, and economics. He is also interested in pharmacoepidemiology with a focus on safety issues in medication treatment and health informatics to improve the quality and safety of patient care.  He has served as principal investigator (PI) and co-PI for more than 30 research grants and contracts from NIH, AHRQ, PCORI, and other public and private funding sources.

Lizheng Shi's Bio

Panelist

Yingyao Chen, Ph.D.

Professor of Health Technology Assessment at Fudan University School of Public Health, Director of the National Health Commission Key Laboratory of Health Technology Assessment at Fudan University, and Director of World Health Organization (WHO) Collaborating Centre for HTA and Management

Yingyao Chen

Professor Yingyao Chen is Professor of Health Technology Assessment at Fudan University School of Public Health, (FUSPH), Director of the National Health Commission Key Laboratory of Health Technology Assessment at Fudan University, and Director of World Health Organization (WHO) Collaborating Centre for Health Technology Assessment and Management, Shanghai, China. In addition, he is the Associate Dean of the FUSPH, responsible for international collaborations.

He received his Bachelor of Medicine and Master of Public Health at Shanghai Medical University in 1991 and 1997, respectively, and his PhD in Management at Fudan University in 2006. He took part in a visiting scholar programme at the University of California, Los Angeles from 1999 to 2001.

Yingyao Chen's Bio

Moderator

Scott M. Tackett, MHA, MPH

Vice President of Global Access, Value & Economics (GAVE); serving as the Executive and Chief Economic Advisor and Market Access Leader for Intuitive

Scott Tackett

Scott M. Tackett, MHA, MPH is currently Vice President of Global Access, Value & Economics (GAVE); serving as the executive and chief economic advisor and market access leader for Intuitive, Sunnyvale, California. In this role, he leads the strategy, management, and operations of the global GAVE organization. His remit is to work with policymakers, payers, major health systems providers, and clinical and economic decisions makers to address concerns related to value of emerging technologies and its delivery of higher quality and cost-effective care. Scott is an applied health economist and strategist with 20+ years of experience in health care management and leadership roles for life sciences companies and U.S. Honor Roll Hospitals. He has led health economic strategy, and market and patient access operations in more than 30 international markets.

He has been published in many clinical, economic and health care strategy peer‐reviewed journals and regularly speaks at global conferences on health care futures, economic strategies, patient access, and the link between value and technology investment as it relates to achieving the “Quadruple Aim in Healthcare.” His research interests have focused on observational evaluations and integrating predictive analytics to deliver “meaningful value transfer” via intelligent medical interventions, effectiveness, and efficiency. Prior to his current role at Intuitive, Scott was Head of Global & U.S. Market Access & Health Economics, and Director of Medical Outcomes Research & Economics at Baxter.

Scott holds a Master of Public Health with an emphasis in international health economics and a Master of Health Administration with an emphasis in health care strategy from Tulane University School of Public Health & Tropical Medicine, New Orleans, Louisiana. He performed a post‐graduate fellowship training and was the David A Gee Fellow at Barnes‐Jewish Hospital at Washington University Medical Center, St. Louis, Missouri. He holds a Bachelor of Arts in biology and chemistry from Central Methodist University, Fayette, Missouri.

Scott Tackett's Bio

Program Sponsor

Intuitive advances minimally invasive care by helping physicians and their teams optimize care delivery to support the best outcomes possible. For nearly three decades we’ve created products and services born of inspiration and intelligence—from robotic-assisted surgical and bronchoscopy systems to data generation that unlocks the potential to benefit care systems worldwide.

We work closely and collaboratively with our customers to help achieve better outcomes, better care team experiences, better patient experiences, lower cost of care, and improved access. Together, we envision a future of care that’s less invasive and profoundly better, where diseases are identified early and treated quickly so patients can get back to what matters most.

Start typing and press enter to search

Scroll to Top